Joseph Altepeter
Foot & Ankle Surgery · Indianapolis, INNPI 1013413426
Payments from drug & device makers
Across 41 payments — averaging $120.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Aroa Biosurgery Incorporated$255
- Medline Industries LP$171
- Orthofix Medical, Inc.$147
- Treace Medical Concepts, Inc.$107
- Stryker$83
- plus $378 from 9 others
What the payments were for
- Food & beverage$1,33027%
- Education$3,60073%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 12 | $3,790 |
| Aroa Biosurgery Incorporated | 2 | $255 |
| Medline Industries LP | 2 | $171 |
| Orthofix Medical, Inc. | 1 | $147 |
| Treace Medical Concepts, Inc. | 5 | $107 |
| Stryker | 2 | $83 |
| Paratek Pharmaceuticals, Inc. | 4 | $81 |
| Smith+Nephew | 4 | $76 |
| DJO, LLC | 3 | $74 |
| Convatec Inc. | 1 | $41 |
| Solventum Corporation | 1 | $33 |
| Coastal Medical Technologies LLC | 1 | $25 |
| AbbVie | 1 | $18 |
| Cashflow Solutions, LLC | 1 | $16 |
| KCI USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,930 in reported general payments places this provider in the 55th percentile of 212 foot & ankle surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 19 | $30,329 |
| Ketoconazole | 78 | $1,190 |
| Gabapentin | 46 | $709 |
| Ciclopirox | 18 | $645 |
| Gentamicin Sulfate | 17 | $500 |
| Diclofenac Sodium | 16 | $301 |
| Terbinafine Hcl | 21 | $266 |
| SsdSilver Sulfadiazine | 36 | $261 |
| Methylprednisolone | 37 | $242 |
| Cephalexin | 17 | $219 |
| Doxycycline Hyclate | 20 | $211 |
| Clindamycin Hcl | 17 | $194 |
| Mupirocin | 22 | $172 |
| Ciprofloxacin Hcl | 13 | $153 |
| Clotrimazole | 13 | $114 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Indianapolis
- Patrick DeheerIndianapolis$493K
- Stephen GreenfieldIndianapolis$52K
- Mihir PatelIndianapolis$28K
- Cathy CokerIndianapolis$23K
- Jered StowersIndianapolis$14K
- Zachary JanesIndianapolis$13K
- Neal PatelIndianapolis$12K
- Tracy WarnerIndianapolis$10K
- Elizabeth ParryIndianapolis$10K
- Steven HerbstMuncie$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.